abstract |
Antisense compounds, compositions, and methods for modulating the expression of endothelium specific molecule-1 (ESM-1) are provided. The composition comprises an antisense compound, particularly an antisense oligonucleotide, targeted to a nucleic acid encoding ESM-1. Methods of using these compounds for modulating ESM-1 expression and treating diseases associated with ESM-1 expression are provided. |